A trial to determine the safety of a novel vaccine for lung cancer will take place at sites across England and Wales. The first UK patient received the jab at the National Institute for Health Research UCLH Clinical Research Facility in August. – But what is the vaccine and how does it work? The vaccine, known as BNT116, utilises messenger RNA (mRNA), the same technology used in the Covid-19 vaccines. The jab works by presenting the immune system with tumour markers from non-small cell lung cancer (NSCLC). This primes the body to fight the cancer cells that are expressing these markets while l…